Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
This triple-action mechanism distinguishes it from existing approved therapies such as semaglutide (GLP-1 receptor agonist only) or tirzepatide (GLP-1/GIP dual agonist)
Hims & Hers Filed in the U.S
Other ingredients De-ionized water, vegetable glycerin, malic acid, citric acid, natural flavors, potassium sorbate (as preservative) and lemon (citrus limon) oil
Fact: Bioavailability is the limiting factor
40+ generic companies gearing up for launch their brands 50-60% price drop expected Treatment option for over 100 million people suffering from diabetes and 130 million suffering from obesity Flourishing an industry of not just drugs but also wellness centers, nutritionists, cosmetic and metabolic clinics
Brands that meet their needs will lead the next decade in the GLP-1 adjacent wellness space
US$ 21.58
US$ 27.05
US$ 27.01
US$ 26.69
US$ 27.74
